To narrow your search, use one or more of the following search menus below.
January 1, 2004
FMS Immunology and Medical Microbiology
Karginov VA, Robinson TM, Riemenschneider J, Golding B, Kennedy M, Shiloach J, Alibek K
Product: Anthrax Lethal Factor (LF), Recombinant from B. anthracis
Reagents:
Recombinant B. anthracis LF and PA (rPA) were acquired from List Biological Laboratories (Campbell, CA, USA). …
Immunization of rabbits and sheep:
Rabbits were immunized s.c. with rPA mixed with Freund’s complete adjuvant (FCA) initially, and with Freund’s incomplete adjuvant (FIA) at the time of boosting 3 and 6 weeks later. Rabbits were bled 1 week after the last immunization. …
Cytotoxicity neutralization test:
LeTx (LF=16 ng ml1 or 64 ng ml1; PA=500 ng ml1) was pre-incubated in DMEM with varying concentrations of the tested antibody for 1 h at 37C in a 5% CO2atmosphere. …
Author did not indicate which specific lethal factor was utilized. List Labs provides Product #172 (Anthrax Lethal Factor (LF), Recombinant from B. anthracis) and Product #169 (Anthrax Lethal Factor (LF-A), Recombinant from B. anthracis Native Sequence).
July 11, 2003
The Journal of Biological Chemistry
Soelaiman S, Wei BQ, Bergson P, Lee YS, Shen Y, Mrksich M, Shoichet BK, Tang WJ
Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis
Materials:
… Anthrax protective antigen was purchased from List Biological Laboratory (Campbell, CA), …
Purification of EF, EF3, CyaA-N, and CaMEF3 and CyaA-N, the catalytic domains of EF and CyaA, respectively, as well as calmodulin were purified as described previously (37,38). To express edema factor that has a hexahistidine tag substituted for its leader peptide (amino acids 133) and can be delivered by anthrax-protective antigen into host cells, a plasmid, pProEx-H6-EF, was constructed as follows. The 3.2-kb EcoRI-XhoI fragment was excised from pSE42 (kindly provided by S. Leppla, National Institutes of Health) and inserted into pBluescript. A NotI site was then introduced at the sequence encoding amino acids 3234 of EF by site-directed mutagenesis, and the mutation was confirmed by DNA sequencing.
April 29, 2003
Proceedings of the National Academy of Sciences of the United States of America
Scobie HM, Rainey GJ, Bradley KA, Young JA
Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis
PA-Binding Studies:
PA binding to CHO-R1.1 cells that expressed CMG2489-EGFP or ATR/TEM8 sv2-EGFP was assessed by flow-cytometric analysis; 106 cells of each type were incubated with 50 nM PA (1 h, 4C), washed with PBS, incubated with a polyclonal PA-specific rabbit antiserum (9) (1:500 dilution, 1 h, 4C), washed with PBS again, and then incubated with an allophycocyanin-conjugated anti-rabbit antibody (Molecular Probes; 1:2,000 dilution, 1 h, 4C). ELISAs were performed by binding 0.3 g of PA83 (List Biological Laboratories, Campbell, CA)/100 l of TBS in a well of a MaxiSorp plate (Nalge). Samples were then treated with TBST solution (TBS containing 3% BSA and 0.05% Tween 20), washed with TBST, and incubated with 0300 ng of purified CMG2VWA/I-MycHis/100 l TBST in the absence or presence of 1 mM MgCl2, MnCl2, CaCl2, or ZnCl2. The samples were then washed with TBST and incubated with a horseradish peroxidase-conjugated anti-His antibody (1:2,000 dilution; Santa Cruz Biotechnology). All incubations for ELISAs were performed for 1 h at room temperature. The levels of bound antibody were then measured by using Supersignal ELISA Pico chemiluminescent substrate (Pierce) and a luminometer (Victor V, Wallac).
Intoxication Assays:
Cell viability assays (WST-1 assay; Roche Molecular Biochemicals) were performed in triplicate by incubating 5,000 cells of each type for 30 h with 2 1010 M LFN-diptheria toxin A chain (DTA) and varying concentrations of PA (1012 to 108 M; List Biological Laboratories) or no PA (100% viability control). The inhibition assays were performed as above with different amounts of CMG2VWA/I-MycHis (01,000 ng/100 l) added to 109 M PA and 1010 M LFN-DTA before this mixture was added to cells. The IC50 was determined by regression analysis (prism, GraphPad, San Diego).
March 30, 2003
List Labs POSTER - Presented at the 5th International Conference on Anthrax, March 30, 2003 in Nice, France
Shine, N., Eaton, L., Crawford, K.
Product: MAPKKide® Peptide Substrate (DABCYL/FITC) for Anthrax Lethal Factor
Materials:
… The purified recombinant anthrax lethal factor (LF) and both MAPKKide substrates are products of List Biological Laboratories.
• Prodcut #172 – Anthrax Lethal Factor (LF), Recombinant from B. anthracis